A citation-based method for searching scientific literature

Rury R Holman, Sanjoy K Paul, M Angelyn Bethel, David R Matthews, H Andrew W Neil. N Engl J Med 2008
Times Cited: 4667



Jennifer B Green, M Angelyn Bethel, Paul W Armstrong, John B Buse, Samuel S Engel, Jyotsna Garg, Robert Josse, Keith D Kaufman, Joerg Koglin, Scott Korn, John M Lachin, Darren K McGuire, Michael J Pencina, Eberhard Standl, Peter P Stein, Shailaja Suryawanshi, Frans Van de Werf, Eric D Peterson, Rury R Holman. N Engl J Med 2015
Times Cited: 1598




List of shared articles



Times cited

Cardioprotective mechanism of SGLT2 inhibitor against myocardial infarction is through reduction of autosis.
Kai Jiang, Yue Xu, Dandan Wang, Feng Chen, Zizhuo Tu, Jie Qian, Sheng Xu, Yixiang Xu, John Hwa, Jian Li,[...]. Protein Cell 2022
15

2022 update to the position statement by Primary Care Diabetes Europe: a disease state approach to the pharmacological management of type 2 diabetes in primary care.
S Seidu, X Cos, S Brunton, S B Harris, S P O Jansson, M Mata-Cases, A M J Neijens, P Topsever, K Khunti. Prim Care Diabetes 2022
1


Management of type 2 diabetes without insulin: An update for the PCP.
Sudha Thiruvengadam, Patricia R Peter. Dis Mon 2022
0

The Cost-Effectiveness of Oral Semaglutide in Spain: A Long-Term Health Economic Analysis Based on the PIONEER Clinical Trials.
Josep Franch-Nadal, Samuel J P Malkin, Barnaby Hunt, Virginia Martín, María Gallego Estébanez, Josep Vidal. Adv Ther 2022
0

Glucagon-like peptide-1 (GLP-1) receptor agonists and their cardiovascular benefits-The role of the GLP-1 receptor.
Johanna Helmstädter, Karin Keppeler, Leonie Küster, Thomas Münzel, Andreas Daiber, Sebastian Steven. Br J Pharmacol 2022
5